The market has shown constant growth in the adoption of cardiac rhythm management devices owing to the increasing prevalence of cardiovascular disorders.
The market was negatively impacted during the COVID-19 pandemic, as elective procedures, including the non-essential cardiovascular procedures, were postponed or canceled during the pandemic.
For instance, in October 2020, Abbott launched its new ICD and CRT-D in India, to expand its product portfolio in the country.